Eye washing is a common over-the-counter, self-administered method for managing hay fever-related ocular symptoms. However, epidemiological data on eyewash users with hay fever and their characteristics are limited. This study aimed to profile eyewash usage and preferences in individuals with hay fever. This digital, cross-sectional cohort study was conducted between February 2018 and May 2020. Individuals in Japan who downloaded the AllerSearch smartphone application were included. Factors associated with eyewash and non-eyewash users among patients with hay fever were assessed using multivariable logistic regression analyses. Of the 11,284 participants, 9,041 had hay fever. Among them, 40.7% were eyewash users (43.9% used eyewash products as needed during symptom flare-ups, 24.8% used them in the morning, and 19.4% in the evening). Factors associated with eyewash use included younger age, previous psychiatric illness, history of contact lens use, current contact lens use, active smoking, higher yogurt intake, lower nasal symptom score, higher non-nasal symptom score, and dry eye symptoms. Non-use of eyewash was linked to older age, sleep duration < 6 h, lower yogurt intake, and dry eye symptoms. This study elucidated characteristics and factors associated with eyewash use among individuals with hay fever, guiding an individualized approach to treatment and public health initiatives.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41598-025-93027-z | DOI Listing |
Sci Rep
March 2025
Department of Ophthalmology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.
Eye washing is a common over-the-counter, self-administered method for managing hay fever-related ocular symptoms. However, epidemiological data on eyewash users with hay fever and their characteristics are limited. This study aimed to profile eyewash usage and preferences in individuals with hay fever.
View Article and Find Full Text PDFPediatr Pulmonol
March 2025
Department of Occupational and Environmental Health/Epidemiology, Bavarian Health and Food Safety Authority, Munich, Germany.
Background: Aim of the study was to investigate the association of IgE sensitizations in serum and self-reported allergic rhinitis (AR) and asthmatic symptoms.
Methods: Between 2015 and 2018, parents of 1190 children in Günzburg, Germany participated in the study by completing a questionnaire. Settings were the Health-Monitoring-Units (HMU) during the obligatory school entry examinations and a medical examination for all German children at the age of 60-64 months (U9).
Asia Pac Allergy
March 2025
Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
Background: Seasonal allergic rhinitis (SAR) is a global health issue, and the current standard of care (SoC) has limited effectiveness in controlling the disease. There is a need for innovative treatments to better manage uncontrolled SAR and advance beyond the uniform SoC, and biologics targeting type 2 inflammation driving allergic rhinitis is promising.
Objective: To evaluate the efficacy and safety of Stapokibart, a humanized monoclonal antibody targeting interleukin-4 receptor subunit alpha, as an add-on therapy in patients with uncontrolled SAR.
Environ Epidemiol
April 2025
Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Background: Prior research suggests pollen allergies may be associated with cognitive function, although the effect sizes and specific cognitive outcomes varied across studies. With pollen seasons starting earlier and intensifying due to climate change, understanding the effects of pollen exposure on cognition is increasingly relevant. This study investigated the relationship between ambient pollen exposure and cognitive performance in Swiss adults.
View Article and Find Full Text PDFAllergy Asthma Proc
March 2025
From the Division of Research and Innovation, Leumit Health Services, Tel Aviv, Israel.
The relationship between fibromyalgia (FM) and allergic diseases remains poorly understood, despite emerging evidence that suggests a possible association. This study aimed to evaluate the prevalence of allergic comorbidities in patients with FM compared with a matched control group. We conducted a retrospective, population-based case-control study within Leumit Health Services, which caters to ∼750,000 members.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!